OLINGER, Eric, SCHAEFFER, Céline, CHENG, Yurong, KÖTTGEN, Anna, RAMPOLDI, Luca und DEVUYST, Olivier, 2022. An intermediate-effect size variant in UMOD confers risk for chronic kidney disease. Freiburg: Universität.
Elsevier - Harvard (with titles)Olinger, E., Schaeffer, C., Cheng, Y., Köttgen, A., Rampoldi, L., Devuyst, O., 2022. An intermediate-effect size variant in UMOD confers risk for chronic kidney disease. Universität, Freiburg. https://doi.org/10.1073/pnas.2114734119
American Psychological Association 7th editionOlinger, E., Schaeffer, C., Cheng, Y., Köttgen, A., Rampoldi, L., & Devuyst, O. (ca. 2022). An intermediate-effect size variant in UMOD confers risk for chronic kidney disease [Cd]. Universität. https://doi.org/10.1073/pnas.2114734119
Springer - Basic (author-date)Olinger E, Schaeffer C, Cheng Y, Köttgen A, Rampoldi L, Devuyst O (2022) An intermediate-effect size variant in UMOD confers risk for chronic kidney disease. Universität, Freiburg
Juristische Zitierweise (Stüber) (Deutsch)Olinger, Eric/ Schaeffer, Céline/ Cheng, Yurong/ Köttgen, Anna/ Rampoldi, Luca/ Devuyst, Olivier, An intermediate-effect size variant in UMOD confers risk for chronic kidney disease, Freiburg 2022.